{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:27:25Z","timestamp":1786962445602,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-026-03252-7","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T09:51:45Z","timestamp":1786960305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["X-linked dystonia parkinsonism as a cause of isolated lingual dystonia (ILD)"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7813-4146","authenticated-orcid":false,"given":"Lowrence Precious","family":"Dichoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Dakay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Westenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerlyn","family":"Leonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-4226","authenticated-orcid":false,"given":"Gerard","family":"Saranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"3252_CR1","doi-asserted-by":"publisher","unstructured":"Albanese A, Bhatia K, Bressman SB et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863\u2013873. https:\/\/doi.org\/10.1002\/mds.25475.","DOI":"10.1002\/mds.25475."},{"key":"3252_CR4","doi-asserted-by":"publisher","unstructured":"Aneichyk T, Hendriks WT, Yadav R et al (2018) Dissecting the causal mechanism of X-linked dystonia-parkinsonism by integrating genome and transcriptome assembly. Cell 172(5):897\u2013909e21. https:\/\/doi.org\/10.1016\/j.cell.2018.02.011","DOI":"10.1016\/j.cell.2018.02.011"},{"key":"3252_CR13","doi-asserted-by":"publisher","unstructured":"Bader B, Walker RH, Vogel M, Prosiegel M, McIntosh J, Danek A (2010) Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis. Mov Disord. 25(1):127\u2013129. https:\/\/doi.org\/10.1002\/mds.22864.","DOI":"10.1002\/mds.22864."},{"key":"3252_CR6","doi-asserted-by":"publisher","first-page":"E11020","DOI":"10.1073\/pnas.1712526114","volume":"114","author":"DC Bragg","year":"2017","unstructured":"Bragg DC, Mangkalaphiban K, Vaine CA et al (2017) Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1. Proc Natl Acad Sci U S A 114:E11020\u2013E11028. https:\/\/doi.org\/10.1073\/pnas.1712526114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3252_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamaneurol.2018.3777","volume":"76","author":"N Br\u00fcggemann","year":"2019","unstructured":"Br\u00fcggemann N, Domingo A, Rasche D et al (2019) Association of pallidal neurostimulation and outcome predictors with X-linked dystonia parkinsonism. JAMA Neurol 76(2):211\u2013216. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3777","journal-title":"JAMA Neurol"},{"key":"3252_CR22","doi-asserted-by":"publisher","unstructured":"Budak F, Aydin E, Kochaya A, Ilbay G (2013) Botulinum toxin in the treatment of lingual dystonia induced by speaking. Case Rep Neurol. 5(2):126\u2013130. https:\/\/doi.org\/10.1159\/000347000.","DOI":"10.1159\/000347000"},{"key":"3252_CR14","doi-asserted-by":"crossref","unstructured":"Burn D, Kennard C (2013) Oxford textbook of Movement Disorders, Oxford university press. Chap. 17, p 180","DOI":"10.1093\/med\/9780199609536.001.0001"},{"key":"3252_CR12","doi-asserted-by":"publisher","unstructured":"Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA (2018) The nosology of tardive syndromes. J Neurol Sci. 389:10\u201316. https:\/\/doi.org\/10.1016\/j.jns.2018.02.015.","DOI":"10.1016\/j.jns.2018.02.015"},{"key":"3252_CR11","doi-asserted-by":"publisher","unstructured":"Gollomp S, Fahn S (1987) Transient dystonia as a complication of varicella. J Neurol Neurosurg Psychiatry. 50(9):1228\u20131229. https:\/\/doi.org\/10.1136\/jnnp.50.9.1228","DOI":"10.1136\/jnnp.50.9.1228"},{"key":"3252_CR17","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1093\/brain\/awy222","volume":"141","author":"H Hanssen","year":"2018","unstructured":"Hanssen H, Heldmann M, Prasuhn J et al (2018) Basal ganglia and cerebellar pathology in X-linked dystonia-parkinsonism. Brain 141:2995\u20133008. https:\/\/doi.org\/10.1093\/brain\/awy222","journal-title":"Brain"},{"key":"3252_CR19","doi-asserted-by":"publisher","unstructured":"Jamora RD, Diesta CC, Pasco PM, Lee LV (2011) Oral pharmacological treatment of X-linked dystonia parkinsonism: successes and failures. Int J Neurosci 121 Suppl 118\u201321. https:\/\/doi.org\/10.3109\/00207454.2010.544433","DOI":"10.3109\/00207454.2010.544433"},{"key":"3252_CR8","doi-asserted-by":"publisher","unstructured":"Laabs B, Klein C, Pozojevic J et al (2021) Identifying genetic modifiers of age-associated penetrance in X-linked dystonia-parkinsonism. Nat Commun 12(1):3216. https:\/\/doi.org\/10.1038\/s41467-021-23491-4","DOI":"10.1038\/s41467-021-23491-4"},{"key":"3252_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1086\/512129","volume":"80","author":"S Makino","year":"2007","unstructured":"Makino S, Kaji R, Ando S et al (2007) Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet 80:393\u2013406. https:\/\/doi.org\/10.1086\/512129","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3252_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0303-8467(91)90006-B","volume":"93","author":"N Oztekin","year":"1991","unstructured":"Oztekin N, Saygi S, Dalkara T et al (1991) High dose anticholinergic therapy (biperiden) in dystonia. Clin Neurol Neurosurg 93(1):35\u201337. https:\/\/doi.org\/10.1016\/0303-8467(91)90006-B","journal-title":"Clin Neurol Neurosurg"},{"key":"3252_CR3","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/mds.28289","volume":"35","author":"MG Pauly","year":"2020","unstructured":"Pauly MG, Ruiz L\u00f3pez M, Westenberger A, Saranza G et al (2020) Expanding data collection for the MDSGene database: X-linked dystonia-parkinsonism as use case example. Mov Disord 35:1933\u20131938. https:\/\/doi.org\/10.1002\/mds.28289","journal-title":"Mov Disord"},{"key":"3252_CR15","doi-asserted-by":"publisher","unstructured":"Quartarone A, Hallett M (2013) Emerging concepts in the physiological basis of dystonia. Mov Disord. 28(7):958\u2013967. https:\/\/doi.org\/10.1002\/mds.25532.","DOI":"10.1002\/mds.25532"},{"key":"3252_CR5","doi-asserted-by":"publisher","unstructured":"Rakovic A, Domingo A, Gr\u00fctz K et al (2018) Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism. Mov Disord. 33(7):1108\u20131118. https:\/\/doi.org\/10.1002\/mds.27441.","DOI":"10.1002\/mds.27441"},{"key":"3252_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/mds.25244","volume":"27","author":"TD Steeves","year":"2012","unstructured":"Steeves TD, Day L, Dykeman J et al (2012) The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 27:1789\u20131796. https:\/\/doi.org\/10.1002\/mds.25244","journal-title":"Mov Disord"},{"key":"3252_CR20","unstructured":"Verma A, Yadav R (2011) Isolated lingual dystonia: responding to anticholinergic treatment. J Assoc Physicians India. 59:526-7."},{"key":"3252_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ana.25488","volume":"85","author":"A Westenberger","year":"2019","unstructured":"Westenberger A, Reyes CJ, Saranza G et al (2019) A hexanucleotide repeat modifies expressivity of X-linked dystonia Parkinsonism. Ann Neurol 85:812\u2013822. https:\/\/doi.org\/10.1002\/ana.25488","journal-title":"Ann Neurol"},{"key":"3252_CR9","doi-asserted-by":"publisher","unstructured":"Yoshida K (2019) Botulinum neurotoxin therapy for lingual dystonia using an individualized injection method based on clinical features. Toxins (Basel). 11:E51. https:\/\/doi.org\/10.3390\/toxins11010051","DOI":"10.3390\/toxins11010051"},{"issue":"11","key":"3252_CR10","first-page":"1511","volume":"126","author":"K Yoshida","year":"2019","unstructured":"Yoshida K (2019) Clinical and phenomenological characteristics of oromandibular dystonia: comparison of jaw-opening, jaw-closing, jaw-deviating, and lingual dystonia. J Neural Transmission 126(11):1511\u20131522","journal-title":"J Neural Transmission"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03252-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03252-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03252-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T09:51:48Z","timestamp":1786960308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03252-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":22,"alternative-id":["3252"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03252-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"13 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.K. has served as medical advisor to Centogene and Biogen, received speakers\u2019 honoraria from Bial, and royalties from Oxford University Press and Springer Nature. G.S. has received research and CME support from the Michael J. Fox Foundation through the Global Parkinson\u2019s Genetics Program (GP2) (MJFF-026331), CME support from the International Parkinson and Movement Disorder Society through the MDS Center to Center Program 2025-2027 (42400-CNT2CNT), and speaker\u2019s honoraria and CME support from various pharmaceutical companies in the Philippines. N.B. has received speaker honoraria from AbbVie, Esteve, Ipsen, Merz, Takeda, Teva, and Zambon.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}